Bulletin
Investor Alert

Market Pulse Archives

March 25, 2019, 7:27 a.m. EDT

Biogen sets new $5 billion stock repurchase program in aftermath of stock plunge

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Biogen Inc. (BIIB)
  • X
    iShares Nasdaq Biotechnology ETF (IBB)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Biogen Inc. /zigman2/quotes/201531540/composite BIIB -0.32% bounced 1.7% in premarket trade Monday, after the drugmaker disclosed that it set a new $5.0 billion stock repurchase program, without an expiration date. The new program is in addition to the $1.7 billion remaining under the program set in August 2018. The new buyback announcement comes after the stock plummeted 32.4% to close Friday at the lowest level since June 2016, after the company said it would discontinue its phase 3 trials of its Alzheimer's treatment, citing results of an interim analysis of trial data. Based on Friday's stock closing price of $216.71, the total buyback authorization would represent about 30.92 million shares, or 15.7% of the shares outstanding. Biogen's stock has shed 16.7% over the past 12 months, while the iShares Nasdaq Biotechnology ETF /zigman2/quotes/206189322/composite IBB +0.51% has gained 2.7% and the S&P 500 /zigman2/quotes/210599714/realtime SPX -1.12% has advanced 8.2%.

/zigman2/quotes/201531540/composite
US : U.S.: Nasdaq
$ 274.48
-0.89 -0.32%
Volume: 3.07M
Sept. 18, 2020 4:00p
P/E Ratio
8.04
Dividend Yield
N/A
Market Cap
$43.45 billion
Rev. per Employee
$1.55M
loading...
/zigman2/quotes/206189322/composite
US : U.S.: Nasdaq
$ 136.32
+0.69 +0.51%
Volume: 2.64M
Sept. 18, 2020 4:00p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,319.47
-37.54 -1.12%
Volume: 4.09B
Sept. 18, 2020 5:15p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.